Item 8.01. Other Events.
Common Stock Dividend
On January 3, 2023, Healthcare Trust, Inc. (the "Company") announced the
declaration of a quarterly stock dividend of 0.014167 shares of the Company's
common stock, $0.01 par value per share (the "Common Stock"), on each share of
the Company's outstanding Common Stock. The stock dividend is payable on January
18, 2023 to holders of record of the Company's Common Stock at the close of
business on January 13, 2023.
As previously announced, dividends authorized by the Company's board of
directors on the Company's shares of Common Stock will be paid on a quarterly
basis in arrears in shares of the Company's Common Stock valued at the Company's
estimated per share net asset value of Common Stock in effect on the applicable
date, which is currently $15.00 per share, based on a single record date to be
specified at the beginning of each quarter. The number of shares to be so issued
will continue to be based on a per share amount equal to $0.85 per annum, or
$0.2125 per quarter. Please see the Company's Current Report on Form 8-K filed
with the SEC on April 1, 2022 for a full description of the determination of the
Company's current estimated per share net asset value of Common Stock and
related assumptions, qualifications and limitations.
The statements in this Current Report on Form 8-K that are not historical facts
may be forward-looking statements. These forward-looking statements involve
risks and uncertainties that could cause actual results or events to be
materially different. The words "anticipates," "believes," "expects,"
"estimates," "projects," "plans," "intends," "may," "will," "would" and similar
expressions are intended to identify forward-looking statements, although not
all forward-looking statements contain these identifying words. These
forward-looking statements are subject to a number of risks, uncertainties and
other factors, many of which are outside of the Company's control, which could
cause actual results to differ materially from the results contemplated by the
forward-looking statements. These risks and uncertainties include (a) the
potential adverse effects of (i) the global COVID-19 pandemic, including actions
taken to contain or treat COVID-19, and (ii) the geopolitical instability due to
the ongoing military conflict between Russia and Ukraine, including related
sanctions and other penalties imposed by the U.S. and European Union, and the
related impact on the Company, the Company's tenants, the Company's operators
and the global economy and financial markets, and (b) that any potential future
acquisition is subject to market conditions and capital availability and may not
be completed on favorable terms, or at all, as well as those risks and
uncertainties set forth in the Risk Factors section of the Company's Annual
Report on Form 10-K for the year ended December 31, 2021 filed on March 18,
2022, and all other filings with the Securities and Exchange Commission after
that date, as such risks, uncertainties and other important factors may be
updated from time to time in the Company's subsequent reports. Further,
forward-looking statements speak only as of the date they are made, and the
Company undertakes no obligation to update or revise any forward-looking
statement to reflect changed assumptions, the occurrence of unanticipated events
or changes to future operating results over time, unless required to do so by
law.
© Edgar Online, source Glimpses